Covance in the news

PETA's undercover investigation exposed severe animal cruelty and neglect at Covance's Virginia laboratory, resulting in USDA citations, fines, and the closure of several Covance animal testing facilities.

PETA conducted an undercover investigation of Covance's primate testing lab in Virginia from April 2004 to March 2005.

An investigation by PETA revealed sick and dying primates at Covance facilities.

Paul McCartney and PETA are campaigning against Covance due to alleged animal cruelty in its drug development services.

Covance faced severe criticism and legal action after a PETA undercover investigation revealed widespread animal abuse and neglect in its laboratories, leading to fines and the closure of facilities.

PETA's investigation uncovered extensive animal cruelty at Covance's Virginia lab, leading to legal action, USDA fines, and facility closures.

Covance, a multibillion-dollar company, uses animals for contract testing and has a history of severe animal welfare violations.

PETA's investigation uncovered extensive animal cruelty at Covance's facilities, leading to legal actions, USDA citations, fines, and ongoing activism against the company's animal testing practices.

Covance is a multi-billion dollar company that conducts animal testing for various client companies using thousands of non-human primates and has a history of animal welfare violations.

Labcorp Drug Development, formerly Covance, saw an 8.8% reduction in its global workforce, from 8,296 employees in 2023 to 7,568 in March 2026.

A protest against animal testing will be held next week in Harrogate at the former Covance facility, now Labcorp, by the campaign group Save The Dogs.

Net sales and profits for the March 2026 quarter showed significant double and triple-digit growth compared to the previous year.

Covance helps medical device and diagnostics companies navigate complex regulations and accelerate product development by offering comprehensive research solutions.

The U.S. Department of Justice has subpoenaed drug development firm Covance for alleged involvement in monkey trafficking and long-standing animal welfare violations.

Covance, a drug development service provider, has been targeted by PETA for decades due to its history of animal cruelty, neglect, and violations in its contract testing facilities and animal supply operations.

Pyxant Labs Inc. acquired Covance by Labcorp's Salt Lake City bioanalytical site to enhance its drug development service capabilities.

Covance is transitioning to a decentralized, siteless clinical trial model using telehealth and digital tools to overcome pandemic-related disruptions.

Covance is partnering with Medable to implement a modular software platform that accelerates the adoption of decentralized clinical trials.

LabCorp introduced cell and gene therapy development solutions from Covance to expedite therapy development and reduce risks for sponsors.

Paul Kirchgraber is the new CEO of Covance as part of a broader leadership reshuffle at parent company LabCorp.